Pulmatrix (PULM) Stock: Buy, Sell, or Hold?
PULM - Pulmatrix, Inc. Common Stock
$1.57
0.03 (1.95%)
â˛
5d:
-2.48%
30d:
+6.8%
90d:
-8.72%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Oct 15, 2026
10d
Get Alerted When PULM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: PULM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: PULM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: PULM is currently trading at $1.57, which is considered slightly high relative to its 30-day fair value range of $1.42 to $1.61.
Technical Outlook: Technically, PULM is in a uptrend. Immediate support is located at $1.39, while resistance sits at $1.78.
Market Sentiment: PULM scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+536.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PULM is in a uptrend. Immediate support is located at $1.39, while resistance sits at $1.78.
Market Sentiment: PULM scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $10.00 (+536.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$1.42 -
$1.61
Company Quality Score
39/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
36.8%
All Signals
- BEARISH: Weak technical setup (20/100)
- BULLISH: Trading 536.9% below Wall St target ($10.00)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.42 -
$1.61
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$1.39
Resistance Level
$1.78
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Wall Street Target
$10.00
(+536.9%)
Revenue Growth (YoY)
-99.9%
Share & Embed Analysis
Last updated: October 03, 2026 8:31 PM ET
Data refreshes hourly during market hours. Next update: 9:31 PM
Data refreshes hourly during market hours. Next update: 9:31 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PULM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 71 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
